Chemical chaperones to the rescue of Alport syndrome?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39174196.
- Also identified by DOI 10.1016/j.kint.2024.07.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alport syndrome is a hereditary kidney disease caused by collagen IV mutations that interfere with the formation and deposition of the α3α4α5 protomer into the glomerular basement membrane. In this issue, Yu et al. show that the chemical chaperone tauroursodeoxycholic acid prevented kidney structural changes and function decline in mice with a pathogenic missense Col4a3 mutation by increasing mutant α3α4α5 protomer glomerular basement membrane deposition and preventing podocyte apoptosis induced by endoplasmic reticulum stress.
Medical subject headings
- Nephritis, Hereditary
- Collagen Type IV
- Taurochenodeoxycholic Acid
- Glomerular Basement Membrane
- Autoantigens